Correction: Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism. - Adolf C; Braun LT; Fuss CT; Hahner S; Künzel H; Handgriff L; Sturm L; Heinrich DA; Schneider H; Bidlingmaier M; Reincke M (Endocrine, 2022)